Related Experiment Video
Updated: Nov 6, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Recent developments in next-generation occlusion devices
Cheng Lin1, Liwu Liu1, Yanju Liu1
1Department of Astronautical Science and Mechanics, Harbin Institute of Technology (HIT), P.O. Box 301, No. 92 West Dazhi Street, Harbin 150001, People's Republic of China.
Insights
Next-generation biodegradable and 3D-printed heart occlusion devices offer safer, minimally invasive alternatives to traditional treatments for congenital heart defects and stroke prevention. These advanced devices promise improved biocompatibility and reduced complications compared to conventional Nitinol occluders.
Area of Science:
- Cardiovascular Medicine
- Biomaterials Science
- Medical Device Engineering
Background:
- Transcatheter closure is a key treatment for congenital heart defects (CHDs) and left atrial appendage (LAA) issues.
- Conventional Nitinol-based occlusion devices face complications like erosion and displacement.
- Minimally invasive approaches are replacing open-heart surgery and long-term medication.
Purpose of the Study:
- To comprehensively review next-generation occlusion devices for treating CHDs and LAA.
- To focus on advancements in materials, configurations, and manufacturing methods.
- To discuss challenges and future directions in occlusion device technology.
Main Methods:
- Review of current literature on novel occlusion devices.
- Analysis of biodegradable and 3D-printed device technologies.
- Examination of deployment strategies and available clinical data.
Main Results:
- Next-generation devices, including biodegradable and 3D-printed options, show promise as alternatives to Nitinol devices.
- These novel devices offer improved biocompatibility, customization, and reduced complication risks.
- Intelligent materials and rapid manufacturing methods like 3D/4D printing are emerging.
Conclusions:
- Next-generation occlusion devices represent a significant advancement in treating heart conditions minimally invasively.
- Biodegradable and customized devices are poised to reduce complications and improve patient outcomes.
- Further research and clinical validation are needed to fully realize the potential of these innovative technologies.
Abstract:
Transcatheter closure has been widely accepted as a highly effective way to treat abnormal blood flows and/or embolization of thrombus in the heart. It allows the closure of four types of congenital heart defects (CHDs) and stroke-associated left atrial appendage (LAA). The four types of CHDs include atrial septal defect (ASD), patent foramen ovale (PFO), patent ductus arteriosus (PDA), and ventricular septal defect (VSD). Advancements in the materials and configurations of occlusion devices have spurred the transition from open-heart surgery with high complexity and morbidity, or lifelong medication with a high risk of bleeding, to minimally invasive deployment. A variety of occlusion devices have been developed over the past few decades, particularly novel ones represented by biodegradable and 3D-printed occlusion devices, which are considered as next-generation alternatives to conventional Nitinol-based occlusion devices due to biodegradability, customization, and improved biocompatibility. The aim here is to comprehensively review the next-generation occlusion devices in terms of materials, configurations, manufacturing methods, deployment strategies, and (if available) experimental results or clinical data. The current challenges and the direction of future work are also proposed. STATEMENT OF SIGNIFICANCE: Implantation of occlusion devices has become a widely accepted and highly effective treatment for occluding abnormal blood/thrombus flow within the heart. Due to the serious complications such as erosion and displacement of conventional Nitinol-based occluders, next-generation occluders with reduced risk of complications and improved biocompatibility has emerged. Here, we comprehensively review the next-generation occluders developed for atrial septal defect (ASD), patent foramen ovale (PFO), patent ductus arteriosus (PDA), ventricular septal defect (VSD), and left atrial appendage (LAA), with special emphasis on biodegradable occluders. Besides, intelligent materials (e.g., automatically deployable shape memory polymers) and rapid customized manufacturing methods (3D/4D printing) for the fabrication of occluders are also introduced. Lastly, the directions of future work are highlighted.
More Related Videos
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Non-ohmic Devices
Consider a simple circuit consisting of a battery, a diode, and a resistor. A...

